Murae Organisor Ltd
Incorporated in 2012, Murae Organisor Ltd
is in the business of pharma commodities
trading[1]
- Market Cap ₹ 165 Cr.
- Current Price ₹ 0.89
- High / Low ₹ 1.37 / 0.53
- Stock P/E 22.0
- Book Value ₹ 1.12
- Dividend Yield 0.00 %
- ROCE 4.21 %
- ROE 5.69 %
- Face Value ₹ 1.00
Pros
- Stock is trading at 0.79 times its book value
- Company has delivered good profit growth of 32.8% CAGR over last 5 years
- Debtor days have improved from 623 to 108 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.10% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 855 | |
0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 845 | |
Operating Profit | 0 | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -1 | 10 |
OPM % | 2% | 3% | 2% | 4% | 7% | 2% | -19% | -21% | 7% | -44% | 1% | |
0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 2 | 0 | |
Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 |
Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | 25% | |
0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 | |
EPS in Rs | 0.07 | 0.11 | 0.23 | 0.42 | 0.02 | 0.00 | 0.03 | 0.02 | 0.00 | 0.04 | ||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 58% |
5 Years: | 73% |
3 Years: | 244% |
TTM: | 33554% |
Compounded Profit Growth | |
---|---|
10 Years: | 53% |
5 Years: | 33% |
3 Years: | 50% |
TTM: | 14940% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -22% |
3 Years: | -12% |
1 Year: | 25% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 5% |
3 Years: | 5% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 186 |
Reserves | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 23 |
0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 213 | |
0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 231 | |
Total Liabilities | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 652 | |
Total Assets | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | -2 | -0 | 0 | -7 | -0 | -3 | -7 | 3 | 0 | -16 | -323 | |
0 | -0 | -0 | -0 | -0 | -0 | -3 | 3 | 0 | 0 | -0 | -0 | |
0 | 2 | 1 | -0 | 7 | 1 | 7 | 3 | -3 | -0 | 28 | 358 | |
Net Cash Flow | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -1 | -0 | -0 | 12 | 35 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,543 | 108 | |
Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | 1 | |
Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | 85 | |
Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,975 | 24 | |
Working Capital Days | 81 | 54 | 58 | 116 | 98 | 126 | 222 | 431 | 698 | 6,342 | 160 | |
ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% | 4% |
Documents
Announcements
-
We Refer To Our Outcome Dated 23Rd July, 2025 With Regard To Fixing Of Record For Bonus Of Equity Shares Of The Company. We Request You To Read The Record Date As Friday, 01St August, 2025 Instead Of Tuesday 29Th July, 2025
1d - Revised record date to 01-Aug-2025 for 1:10 bonus equity shares issue.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
1d - Shareholders approved 1:10 bonus shares and increased authorized capital by ₹15 crore.
-
Intimation Of Record Date For Ascertaining The Eligibility Of The Shareholders Entitled To Bonus Of Equity Shares
23 Jul - Record date set as July 29, 2025, for 1:10 bonus equity shares allotment.
-
Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 (LODR) - Outcome Of The Board Meeting Held Today I.E, 23Rd July 2025.
23 Jul - Board fixed July 29, 2025 as record date for bonus equity shares allotment.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Jul
Business Overview:[1][2][3]
a) MOL is in the business of manufacturing Pharmaceutical, Nutraceutical, Ayurvedic
Herbal products, and trading of pharma
products.
b) It acts as a commission agent in pharma products etc.
c) It provides premium cattle feed which is formulated to support livestock health and performance, while its fertilizers and chemicals are designed to optimize crop yields and ensure safety.
d) It also offers expertise in the gold sector, providing insights and services related to this precious metal